読み込み中
Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing artificial intelligence to deliver comprehensive molecular profiling services to clients both in the United States and internationally. The company is dedicated to transforming medical care by innovating and bringing to market advanced solutions that leverage molecular data and sophisticated machine learning algorithms. Its extensive suite of molecular diagnostic offerings includes MI Profile, a specialized solution analyzing tissue samples, and Caris Assure, a blood-based test designed for cancer treatment applications. Furthermore, Caris provides research and development support to biopharmaceutical customers, encompassing laboratory delivery, strategic data insights, and dedicated research initiatives. Established in 2008, the company maintains its corporate headquarters in Irving, Texas.
前日終値
$29.70
+$2.20 · +8.00%
日中の時刻はETです。市場データは遅延する場合があります。
Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing artificial intelligence to deliver comprehensive molecular profiling services to clients both in the United States and internationally. The company is dedicated to transforming medical care by innovating and bringing to market advanced solutions that leverage molecular data and sophisticated machine learning algorithms. Its extensive suite of molecular diagnostic offerings includes MI Profile, a specialized solution analyzing tissue samples, and Caris Assure, a blood-based test designed for cancer treatment applications. Furthermore, Caris provides research and development support to biopharmaceutical customers, encompassing laboratory delivery, strategic data insights, and dedicated research initiatives. Established in 2008, the company maintains its corporate headquarters in Irving, Texas.
日中レンジ
現在 $29.70
52週レンジ
現在 $29.70
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
中立
バリュエーション
75
割安
センチメント
65
強気
リスク
62
高リスク
モメンタム
29
弱含み
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing artificial intelligence to deliver comprehensive molecular profiling services to clients both in the United States and internationally. The company is dedicated to transforming medical care by innovating and bringing to market advanced solutions that leverage molecular data and sophisticated machine learning algorithms. Its extensive suite of molecular diagnostic offerings includes MI Profile, a specialized solution analyzing tissue samples, and Caris Assure, a blood-based test designed for cancer treatment applications. Furthermore, Caris provides research and development support to biopharmaceutical customers, encompassing laboratory delivery, strategic data insights, and dedicated research initiatives. Established in 2008, the company maintains its corporate headquarters in Irving, Texas.
日中レンジ
現在 $29.70
52週レンジ
現在 $29.70
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標（USD） | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2020年度 |
|---|---|---|---|---|---|
| 売上高 | 8.12億 USD | 4.12億 USD | 3.06億 USD | 2.58億 USD | 2.94億 USD |
| 売上原価 | 2.73億 USD | 2.33億 USD | 2.17億 USD | 1.78億 USD | 1.1億 USD |
| 粗利益 | 5.39億 USD | 1.79億 USD | 8931万 USD | 8002.2万 USD | 1.84億 USD |
| 研究開発 | 4531.4万 USD | 1.14億 USD | 1.17億 USD | 1.01億 USD | — |
| 販売・一般管理 | 3.92億 USD | 3.22億 USD | 2.91億 USD | 2.95億 USD | 2731.2万 USD |
| 営業費用 | 4.94億 USD | 4.36億 USD | 4.09億 USD | 3.96億 USD | 4507万 USD |
| 受取利息 | 1649.7万 USD | 712.2万 USD | 1125.8万 USD | 94.7万 USD | — |
| 支払利息 | 5685.3万 USD | 5002.5万 USD | 3161万 USD | 2668万 USD | 6156.5万 USD |
| 減価償却費と償却費 | 2261.5万 USD | 4891.3万 USD | 4900.1万 USD | 4825.3万 USD | 1.11億 USD |
| 営業利益 | 4511.3万 USD | −2.57億 USD | −3.2億 USD | −3.16億 USD | 1.39億 USD |
| 純利益 | −5.38億 USD | −2.82億 USD | −3.41億 USD | −3.21億 USD | 2773.3万 USD |
会社概要が更新されました 2026年10月11日.
直近の発表実績
直近の発表実績
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
平均目標
$27.25
下落余地（8.25%）この株式へのエクスポージャーを報告している上場投資信託です。
Vanguard Morningstar Total Stock Market ETFVTI1.03億0.00%2.3兆 USD0.03%$381.94+0.63%
Vanguard Morningstar Small-Cap ETFVB7457.03万0.04%1853億 USD0.03%$289.48+0.64%
Vanguard Morningstar Small-Cap Growth ETFVBK4293.1万0.09%447億 USD0.05%$344.74+1.22%
iShares Biotechnology ETFIBB2706.99万0.26%108.2億 USD0.44%$206.49+3.00%
First Trust Health Care AlphaDEX FundFXH2576.72万2.31%11.13億 USD0.61%$130.15+1.37%
Schwab U.S. Small-Cap ETFSCHA1850.64万0.08%218.24億 USD0.03%$32.79+0.40%
iShares Russell Mid-Cap Growth ETFIWP1714.51万0.09%200.95億 USD0.23%$143.1+1.56%
iShares Russell Mid-Cap ETFIWR1418.74万0.03%567.65億 USD0.18%$109.82+0.87%Vanguard Morningstar Total Stock Market ETFVTIVanguard Morningstar Small-Cap ETFVBVanguard Morningstar Small-Cap Growth ETFVBKiShares Biotechnology ETFIBBFirst Trust Health Care AlphaDEX FundFXHSchwab U.S. Small-Cap ETFSCHAiShares Russell Mid-Cap Growth ETFIWPiShares Russell Mid-Cap ETFIWRAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
